Aern.Ns
AERN.NS operates in the Commodity Chemicals industry, producing and selling chemical products primarily used in industrial applications.
Business. AERN.NS operates in the Commodity Chemicals industry, producing and selling chemical products primarily used in industrial applications.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
AERN.NS operates in the Commodity Chemicals industry, producing and selling chemical products primarily used in industrial applications.
AERN.NS has a debt-to-equity ratio of 0.45, indicating a relatively conservative capital structure with a moderate reliance on debt financing. The company's liquidity is assessed as medium, with a current ratio of 1.78, suggesting it can cover its short-term obligations but with limited excess capacity. However, the company reported negative operating cash flow of -88.39 million and free cash flow of -197.03 million, signaling potential liquidity constraints in the near term.
In terms of profitability, AERN.NS has a return on equity (ROE) of 13.21% and a return on assets (ROA) of 6.47%. These figures are below the industry median for ROE and ROA in the Commodity Chemicals sector, indicating that the company is underperforming relative to its peers in generating returns from equity and total assets.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic downturns and regulatory changes. The absence of segment or geographic breakdown in the financial data limits the ability to assess risk distribution.
AERN.NS reported revenue of 2.15 billion in the latest period, with no prior period data provided to assess growth. The company's capital expenditures were -362.50 million, indicating a significant investment in long-term assets. However, the negative free cash flow suggests that these investments are not yet generating sufficient returns to cover operating costs and capital outlays.
The company's risk profile includes medium liquidity risk due to negative net cash after subtracting total debt. Dilution risk is assessed as low, with no near-term pressure from share issuance or convertible instruments. However, the negative operating and free cash flows may necessitate future financing, which could introduce dilution risk if not managed through internal cash generation.
Recent filings and transcripts do not provide specific details on strategic initiatives or operational changes. The company's financial performance and capital structure suggest a need for improved cash flow generation and cost management to sustain operations and support future growth.
- AERN.NS has a conservative capital structure with a debt-to-equity ratio of 0.45, but negative operating and free cash flows indicate liquidity constraints.
- The company's ROE of 13.21% and ROA of 6.47% are below industry medians, suggesting underperformance in profitability.
- Revenue is concentrated in a single segment with no geographic diversification, increasing exposure to regional risks.
- Capital expenditures of -362.50 million indicate significant investment, but negative free cash flow suggests these investments are not yet generating returns.
- Medium liquidity risk and low dilution risk are key risk factors, with potential for future dilution if cash flow does not improve.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- AERN.NS Market data — financials · 2026-05-27
Ownership & reference
Leadership
- Chirag Chandulal PatelManaging Director (Promoter)